Maxime Schreurs

Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET

Marion Chomet, Maxime Schreurs, Maria J. Bolijn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 83 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by ⁸⁹Zr-immuno-PET in xenograft bearing mice

Marion Chomet, Maxime Schreurs, Margaret Nguyen et al. · Theranostics · 2020 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

An in vitro comparison of subjective image quality of panoramic views acquired via 2D or 3D imaging

Pisha Pittayapat, Dimitra Galiti, Yan Huang et al. · Clinical Oral Investigations · 2012 · 29 citations · Full text

Arts, Oral Radiology, Computer Vision +14

Advancing ⁸⁹Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential

Thomas Wuensche, Natascha Stergiou, Iris Mes et al. · Theranostics · 2022 · 29 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody

Natascha Stergiou, Thomas Wuensche, Maxime Schreurs et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 28 citations · Full text

Pharmacy, Neurology, Neuroscience +17